Table 3.
Outcomes of the entire study population and subgroups of patients who received adjuvant trastuzumab and those who did not receive adjuvant trastuzumab.
Variables | All patients N = 91 (%) |
Treatment group N = 39 (%) |
Control N = 52 (%) |
p value |
---|---|---|---|---|
Recurrence | 12 (13) | 3 (10) | 9 (17) | 0.22 |
Biopsy proven | 12 | 3 | 9 | |
Type of recurrence | ||||
Local | 6 (7) | 1 (3) | 5 (10) | 0.23 |
Distant | 1 (2) | 0 | 1 (2) | 1.0 |
New primary cancer | 5 (6) | 2 (6) | 3 (6) | 1.0 |
Breast cancer recurrence | 7 (8) | 1 (3) | 6 (12) | 0.23 |